相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carcinoembryonic antigen, α-fetoprotein, and Ki67 as biomarkers and prognostic factors in intrahepatic cholangiocarcinoma: A retrospective cohort study
Zeyuan Qiang et al.
ANNALS OF HEPATOLOGY (2021)
Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage
Ping Luo et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
Lang Chen et al.
CANCER MEDICINE (2020)
Clinical significance of preoperative CA19-9 and lymph node metastasis in intrahepatic cholangiocarcinoma
Tadafumi Asaoka et al.
SURGERY TODAY (2020)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases
Sunyoung Kim et al.
SCIENTIFIC REPORTS (2020)
Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma
Satoki Kojima et al.
ANTICANCER RESEARCH (2020)
Advances in the early diagnosis of hepatocellular carcinoma
Weiyi Wang et al.
GENES & DISEASES (2020)
Clinical Significance of Preoperative Serum CEA, CA125, and CA19-9 Levels in Predicting the Resectability of Cholangiocarcinoma
Tianyi Fang et al.
DISEASE MARKERS (2019)
Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma
Wataru Izumo et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Tumor markers: myths and facts unfolded
S. C. Faria et al.
ABDOMINAL RADIOLOGY (2019)
Biomarkers for the Diagnosis of Cholangiocarcinoma: A Systematic Review
Gyem Tshering et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
CA19-9 in intrahepatic cholangiocarcinoma. A diagnostic and prognostic armamentarium?
B. Juntermanns et al.
CHIRURG (2018)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy
Long Ge et al.
BMJ OPEN (2017)
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
Sven H. Loosen et al.
SCIENTIFIC REPORTS (2017)
Identification of bile survivin and carbohydrate antigen 199 in distinguishing cholangiocarcinoma from benign obstructive jaundice
Yanfeng Liu et al.
BIOMARKERS IN MEDICINE (2017)
Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review
Yandiswa Yolanda Yako et al.
PLOS ONE (2016)
Epidemiology of cholangiocarcinoma
Annika Bergquist et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2015)
Hepatolithiasis and intrahepatic cholangiocarcinoma: A review
Hyo Jung Kim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Incidence of Cholangiocarcinoma with or without Previous Resection of Liver for Hepatolithiasis
Joon Young Lee et al.
GUT AND LIVER (2013)
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy
Wen-jun Ma et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
CA125 in ovarian cancer
Nathalie Scholler et al.
BIOMARKERS IN MEDICINE (2007)
CT differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis
Hee Sun Park et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
Epidemiology, pathogenesis, and classification of biliary stones (common bile duct and intrahepatic)
Susumu Tazuma
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2006)
Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy
AE Sirica
HEPATOLOGY (2005)
Hepatolithiasis - Epidemiology and pathogenesis update
J Shoda et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
分享论文
